The use of transfusion quality indicators as a tool for hemovigilance system implementation at a tertiary care center in Saudi Arabia

References

1. ↵
   1. de Vries RRP,
   2. Faber J,
   3. Strengers PFW

   (2011) Members of the Board of the International Haemovigilance Network Haemovigilance: an effective tool for improving transfusion practice. Vox Sang 100:60–67.

   OpenUrlCrossRefPubMed
2. ↵
   1. AuBuchon JP,
   2. Dzik WS

   (2010) Reports on clinical transfusion medicine in the early days of transfusion. Transfusion 50:963–967.

   OpenUrl
3. ↵
   1. Carneiro-Proietti A

   (2013) Hemovigilance: a system to improve the whole transfusion chain. Rev Bras Hematol Hemoter 35:158–159.

   OpenUrl
4. ↵
   1. de Vries RRP,
   2. Faber JC

   1. Renaudier P

   (2012) in Hemovigilance: An effective tool for improving transfusion safety, The French Hemovigilance network: from the blood scandal to epidemiologic surveillance of the transfusion chain, eds de Vries RRP, Faber JC (Wiley-Blackwell, Oxford (UK)), pp 147–158.
5. ↵
   1. Bolton-Maggs PHB,
   2. Cohen H

   (2013) Serious hazards of transfusion (SHOT) haemovigilance and progress is improving transfusion safety. Br J Haematol 163:303–314.

   OpenUrlCrossRefPubMed
6. ↵
   1. In de Vries RRP,
   2. Faber JC

   (2012) Hemovigilance: an effective tool for improving transfusion (Wiley-Blackwell, Oxford (UK)).
7. ↵
   1. International Haemovigilance Network

   Welcome to the International Haemovigilance Network, Available from: http://www.ihn-org.com/. Updated 2015 cited 2015 mOctober 6.
8. ↵
   1. World Health Organization

   (2011) Global database on blood safety report 2011 (World Health Organization, eneva (SZ)) Available from URL: http://www.who.int/bloodsafety/global_database/en/.
9. ↵
   1. The Executive Board of Health Ministers’ Council for GCC states

   Blood transfusion services, Available from URL: http://sgh.org.sa/en-us/technicalprograms/healthcare/bloodbankstransfusionservices.aspx. Updated 2014 October 6; Accessed 2015 September 5.
10. ↵
    1. Marwaha N,
    2. Sharma R,
    3. Agnihotri N

    (2012) Analysis of adverse events and predisposing factors in voluntary and replacement whole blood donors: A study from north India. Asian Journal of Transfusion Science 6:155.

    OpenUrl
11. ↵
    1. Diekamp U,
    2. Gneißl J,
    3. Rabe A,
    4. Kießig S

    (2015) Donor hemovigilance with blood donation. Transfus Med Hemother 42:181–192.

    OpenUrl
12. ↵
    1. Tsantes AE,
    2. Kyriakou E,
    3. Nikolopoulos GK,
    4. Stylos D,
    5. Sidhom M,
    6. Bonovas S,
    7. et al.

    (2014) Cost-effectiveness of leucoreduction for prevention of febrile non-haemolytic transfusion reactions. Blood Transfus 12:232–237.

    OpenUrl
13. ↵
    1. Ayob Y

    (2010) Hemovigilance in developing countries. Biologicals 38:91–96.

    OpenUrlPubMed
14. ↵
    1. Maskens C,
    2. Downie H,
    3. Wendt A,
    4. Lima A,
    5. Merkley L,
    6. Lin Y,
    7. et al.

    (2014) Hospital-based transfusion error tracking from 2005 to 2010: identifying the key errors threatening patient transfusion safety. Transfusion 54:66–73.

    OpenUrl
15. ↵
    1. Raval J,
    2. Mazepa M,
    3. Russell S,
    4. Immel C,
    5. Whinna H,
    6. Park Y

    (2015) Passive reporting greatly underestimates the rate of transfusion-associated circulatory overload after platelet transfusion. Vox Sang 108:387–392.

    OpenUrlCrossRefPubMed